{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T16:31:18Z","timestamp":1778085078405,"version":"3.51.4"},"reference-count":96,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s559328","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T14:45:13Z","timestamp":1771857913000},"page":"1-21","source":"Crossref","is-referenced-by-count":1,"title":["Fibroblast Growth Factor Receptor\u202f(FGFR) Inhibitors for the Treatment of Cholangiocarcinoma: Key Therapeutic Developments and Knowledge Gaps"],"prefix":"10.2147","volume":"Volume 20","author":[{"given":"Enes","family":"Erul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8847-3392","authenticated-orcid":true,"given":"Sergio","family":"Cifuentes-Canaval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akhil","family":"Santhosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7015-7378","authenticated-orcid":true,"given":"Emir","family":"Sokolovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Della Mura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardo","family":"Cazzato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u0131nar","family":"Kubilay Tolunay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/MOG.0b013e3282fbf9b3","volume":"24","author":"Sripa","year":"2008","journal-title":"Curr Opin Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","volume":"21","author":"Saha","year":"2016","journal-title":"Oncologist"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jhep.2019.11.020","volume":"72","author":"Mazzaferro","year":"2020","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/S0140-6736(23)00727-4","volume":"401","author":"Kelley","year":"2023","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"EVIDoa2200015","DOI":"10.1056\/EVIDoa2200015","volume":"1","author":"Oh","year":"2022","journal-title":"NEJM Evidence"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17512433.2025.2590695","volume":"18","author":"Rizzo","year":"2025","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.3390\/cancers15051578","volume":"15","author":"Gupta","year":"2023","journal-title":"Cancers"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.6004\/jnccn.2021.0022","volume":"19","author":"Benson","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.annonc.2022.10.506","volume":"34","author":"Vogel","year":"2023","journal-title":"Ann Oncol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"362","DOI":"10.37349\/etat.2022.00087","volume":"3","author":"Arrichiello","year":"2022","journal-title":"Explor Target Antitumor Ther"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nrc2780","volume":"10","author":"Turner","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1002\/hep.26890","volume":"59","author":"Arai","year":"2014","journal-title":"Hepatology"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1053\/j.gastro.2013.01.001","volume":"144","author":"Sia","year":"2013","journal-title":"Gastroenterology"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1470-2045(20)30109-1","volume":"21","author":"Abou-Alfa","year":"2020","journal-title":"Lancet Oncol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S2468-1253(21)00196-5","volume":"6","author":"Javle","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1056\/NEJMoa2206834","volume":"388","author":"Goyal","year":"2023","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nrc.2017.8","volume":"17","author":"Babina","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1002\/cncr.30254","volume":"122","author":"Javle","year":"2016","journal-title":"Cancer"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1158\/2159-8290.CD-13-0050","volume":"3","author":"Wu","year":"2013","journal-title":"Cancer Discov"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1158\/2159-8290.CD-16-1000","volume":"7","author":"Goyal","year":"2017","journal-title":"Cancer Discov"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1158\/2159-8290.CD-20-1669","volume":"11","author":"Cleary","year":"2021","journal-title":"Cancer Discov"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1177\/1756283X17698090","volume":"10","author":"Lee","year":"2017","journal-title":"Therap Adv Gastroenterol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-18-0078","volume":"24","author":"Lowery","year":"2018","journal-title":"Clin Cancer Res"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"16052","DOI":"10.18632\/oncotarget.14109","volume":"8","author":"Chae","year":"2017","journal-title":"Oncotarget"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41571-024-00869-z","volume":"21","author":"Katoh","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s12029-025-01214-y","volume":"56","author":"Seraji","year":"2025","journal-title":"J Gastrointest Cancer"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1186\/s12885-020-07365-4","volume":"20","author":"Ueno","year":"2020","journal-title":"BMC Cancer"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1494520","DOI":"10.3389\/fimmu.2024.1494520","volume":"15","author":"Yang","year":"2024","journal-title":"Front Immunol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e16191","DOI":"10.1200\/JCO.2025.43.16_suppl.e16191","volume":"43","author":"Yu","year":"2025","journal-title":"J Clin Oncol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11523-023-01024-x","volume":"19","author":"Frampton","year":"2024","journal-title":"Target Oncol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/cpdd.1038","volume":"11","author":"Ji","year":"2022","journal-title":"Clin Pharmacol Drug Dev"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/psp4.12805","volume":"11","author":"Ji","year":"2022","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.annonc.2022.02.001","volume":"33","author":"Subbiah","year":"2022","journal-title":"Ann Oncol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"103488","DOI":"10.1016\/j.esmoop.2024.103488","volume":"9","author":"Vogel","year":"2024","journal-title":"ESMO Open"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e2100414","DOI":"10.1200\/PO.21.00414","volume":"6","author":"Bibeau","year":"2022","journal-title":"JCO Precis Oncol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyae204","volume":"30","author":"Saverno","year":"2025","journal-title":"Oncologist"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.2217\/fon-2020-0429","volume":"16","author":"Bekaii-Saab","year":"2020","journal-title":"Future Oncol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s40265-021-01567-1","volume":"81","author":"Kang","year":"2021","journal-title":"Drugs"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"5145","DOI":"10.2147\/OTT.S272208","volume":"14","author":"Yu","year":"2021","journal-title":"Onco Targets Ther"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S2468-1253(21)00220-X","volume":"6","author":"Neuzillet","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/S1470-2045(21)00027-9","volume":"22","author":"Lamarca","year":"2021","journal-title":"Lancet Oncol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1200\/JCO.2024.42.3_suppl.516","volume":"42","author":"Abou-Alfa","year":"2024","journal-title":"J Clin Oncol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1093\/oncolo\/oyad149","volume":"28","author":"Javle","year":"2023","journal-title":"Oncologist"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"4986","DOI":"10.1158\/0008-5472.CAN-19-2568","volume":"80","author":"Sootome","year":"2020","journal-title":"Cancer Res"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"e19541","DOI":"10.1016\/j.heliyon.2023.e19541","volume":"9","author":"Wekking","year":"2023","journal-title":"Heliyon"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1200\/JCO.2022.40.4_suppl.440","volume":"40","author":"Borad","year":"2022","journal-title":"J Clin Oncol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.1200\/JCO.2024.42.16_suppl.4121","volume":"42","author":"Pant","year":"2024","journal-title":"J Clin Oncol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.SABCS22-OT3-24-01","volume":"83","author":"Kamath","year":"2023","journal-title":"Cancer Res"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/bjc.2017.330","volume":"117","author":"Papadopoulos","year":"2017","journal-title":"Br J Cancer"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41416-018-0334-0","volume":"120","author":"Mazzaferro","year":"2019","journal-title":"Br J Cancer"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"4572","DOI":"10.1158\/1078-0432.CCR-24-0012","volume":"30","author":"Grivas","year":"2024","journal-title":"Clin Cancer Res"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1200\/JCO.2024.42.3_suppl.471","volume":"42","author":"Furuse","year":"2024","journal-title":"J Clin Oncol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"e514","DOI":"10.1093\/oncolo\/oyad338","volume":"29","author":"Piha-Paul","year":"2024","journal-title":"Oncologist"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S2468-1253(25)00230-4","volume":"11","author":"Javle","year":"2026","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref57","unstructured":"A phase III, randomized, controlled, global multicenter study to evaluate the efficacy and safety of oral tinengotinib vs physician\u2019s choice in subjects with FGFR-altered, chemotherapy- and FGFR inhibitor-cholangiocarcinoma [Internet]. 2023. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05948475. Accesssed February 19, 2025."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"S234","DOI":"10.1016\/j.annonc.2025.08.515","volume":"36","author":"Javle","year":"2025","journal-title":"Ann Oncol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/S0959-8049(22)00846-2","volume":"174","author":"Allen","year":"2022","journal-title":"Eur J Cancer"},{"key":"ref60","unstructured":"A phase 1\/2 study of a selective FGFR2\/3 inhibitor, CGT4859, in patients with cholangiocarcinoma and other advanced solid tumors harboring FGFR2 and\/or FGFR3 genetic alterations [Internet]. 2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06777316. Accesssed February 19, 2025."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1158\/1078-0432.CCR-23-2646","volume":"30","author":"Meric-Bernstam","year":"2024","journal-title":"Clin Cancer Res"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"e316","DOI":"10.1002\/onco.13552","volume":"26","author":"Lacouture","year":"2021","journal-title":"Oncologist"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1200\/JCO.2017.75.5009","volume":"36","author":"Javle","year":"2018","journal-title":"J Clin Oncol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"e0144119","DOI":"10.1371\/journal.pone.0144119","volume":"10","author":"Ghimire","year":"2015","journal-title":"PLoS One"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.3390\/cancers13122968","volume":"13","author":"Kommalapati","year":"2021","journal-title":"Cancers"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.6004\/jadpro.2024.15.8.2","author":"Schwartz","year":"2024","journal-title":"J Adv Pract Oncol"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1056\/NEJMoa1817323","volume":"381","author":"Loriot","year":"2019","journal-title":"N Engl J Med"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"102170","DOI":"10.1016\/j.ctrv.2021.102170","volume":"95","author":"Goyal","year":"2021","journal-title":"Cancer Treat Rev"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/s41416-020-01157-0","volume":"124","author":"Krook","year":"2021","journal-title":"Br J Cancer"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1158\/1078-0432.CCR-23-1317","volume":"30","author":"Wu","year":"2024","journal-title":"Clin Cancer Res"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.annonc.2024.12.011","volume":"36","author":"Goyal","year":"2025","journal-title":"Ann Oncol"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.annonc.2022.09.150","volume":"33","author":"Berchuck","year":"2022","journal-title":"Ann Oncol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"1616064","DOI":"10.3389\/fcell.2025.1616064","volume":"13","author":"Wang","year":"2025","journal-title":"Front Cell Develop Biol"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1146\/annurev-med-042921-024707","volume":"74","author":"Vogel","year":"2023","journal-title":"Annu Rev Med"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1200\/PO.20.00178","volume":"5","author":"Varghese","year":"2021","journal-title":"JCO Precis Oncol"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1158\/2159-8290.CD-21-1168","volume":"12","author":"Wu","year":"2022","journal-title":"Cancer Discov"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3390\/ijms25020849","volume":"25","author":"Shan","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.trecan.2021.11.001","volume":"8","author":"Saborowski","year":"2022","journal-title":"Trends Cancer"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/hep.31799","volume":"74","author":"Kendre","year":"2021","journal-title":"Hepatology"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jhep.2021.02.032","volume":"75","author":"Cristinziano","year":"2021","journal-title":"J Hepatol"},{"key":"ref81","unstructured":"A phase 3, open-label, randomized study of futibatinib versus gemcitabine-cisplatin chemotherapy as first-line treatment of patients with advanced cholangiocarcinoma harboring FGFR2 gene rearrangements FOENIX-CCA3 [Internet]. 2019. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04093362. Accesssed February 19, 2025."},{"key":"ref82","unstructured":"A Phase I, multi-center, open label, dose de-escalation and expansion study of gemcitabine and cisplatin with AG120 or pemigatinib for advanced cholangiocarcinoma [Internet]. 2019. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04088188. Accesssed February 19, 2025."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"2021619","DOI":"10.1080\/2162402X.2021.2021619","volume":"11","author":"Kono","year":"2022","journal-title":"Oncoimmunology"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1158\/2326-6066.CIR-18-0595","volume":"7","author":"Palakurthi","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1158\/0008-5472.CAN-20-2426","volume":"82","author":"Adachi","year":"2022","journal-title":"Cancer Res"},{"key":"ref86","unstructured":"Prospective S-A. Multicenter Phase II study of evaluation of the efficacy and safety of pemigatinib combined with PD-1 inhibitor in first-line treatment of unresectable or metastatic intrahepatic cholangiocarcinoma [Internet]. 2023. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05913661. Accesssed February 19, 2025."},{"key":"ref87","unstructured":"A phase II single-arm, open-label study of atezolizumab and derazantinib for patients with advanced intrahepatic cholangiocarcinoma with FGFR2 [Internet]. 2021. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05174650. Accesssed February 19, 2025."},{"key":"ref88","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41392-024-01760-0","volume":"9","author":"Duan","year":"2024","journal-title":"Signal Transduction Targeted Ther"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1038\/s41598-024-52991-8","volume":"14","author":"Brandi","year":"2024","journal-title":"Sci Rep"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.3390\/cells11233929","volume":"11","author":"Chmiel","year":"2022","journal-title":"Cells"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"104224","DOI":"10.1016\/j.critrevonc.2023.104224","volume":"194","author":"Fassan","year":"2024","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.3390\/jcm9092854","volume":"9","author":"Lamarca","year":"2020","journal-title":"J Clin Med"},{"key":"ref93","volume-title":"FIGHT: A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Bemarituzumab (Bema) Combined with Modified FOLFOX6 in 1L FGFR2b+ Advanced Gastric\/Gastroesophageal Junction Adenocarcinoma (GC)","year":"2021"},{"key":"ref94","unstructured":"A Phase 1b\/2, multicenter, open-label basket study evaluating the safety and efficacy of bemarituzumab monotherapy in solid tumors with FGFR2b overexpression (FORTITUDE-301) [Internet]. 2022. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05325866. Accesssed February 19, 2025."},{"key":"ref95","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s11523-019-00670-4","volume":"14","author":"Kim","year":"2019","journal-title":"Target Oncol"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1080\/17474124.2024.2416230","volume":"18","author":"Deiana","year":"2024","journal-title":"Expert Rev Gastroenterol Hepatol"}],"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/112349","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/112349","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T14:45:19Z","timestamp":1771857919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/fibroblast-growth-factor-receptorfgfr-inhibitors-for-the-treatment-of--peer-reviewed-fulltext-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":96,"URL":"https:\/\/doi.org\/10.2147\/dddt.s559328","relation":{},"ISSN":["1177-8881"],"issn-type":[{"value":"1177-8881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]}}}